|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$394.19 |
$396.14 |
$391.01 |
$393.48 |
949.10K | 04/19/2024 |
$394.72 |
$396.98 |
$391.25 |
$394.28 |
1.34M | 04/22/2024 |
$397.30 |
$406.34 |
$396.00 |
$399.92 |
1.39M | 04/23/2024 |
$404.00 |
$406.86 |
$403.47 |
$404.91 |
1.07M | 04/24/2024 |
$404.50 |
$406.83 |
$399.29 |
$400.76 |
805.90K |
|
Vertex Pharmaceuticals is a biotechnology company. Co. has clinical and research programs to develop treatment of cystic fibrosis. In addition, Co. has a pipeline of investigational therapies in other diseases where it is utilizing insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. Co.'s marketed CF medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor). | |
|
Vertex Pharmaceuticals (VRTX) has the following price history information. Looking back at VRTX historical stock prices for the last five trading days, on April 18, 2024, VRTX opened at $394.19, traded as high as $396.14 and as low as $391.01, and closed at $393.48. Trading volume was a total of 949.10K shares. On April 19, 2024, VRTX opened at $394.72, traded as high as $396.98 and as low as $391.25, and closed at $394.28. Trading volume was a total of 1.34M shares. On April 22, 2024, VRTX opened at $397.30, traded as high as $406.34 and as low as $396.00, and closed at $399.92. Trading volume was a total of 1.39M shares. On April 23, 2024, VRTX opened at $404.00, traded as high as $406.86 and as low as $403.47, and closed at $404.91. Trading volume was a total of 1.07M shares. On April 24, 2024, VRTX opened at $404.50, traded as high as $406.83 and as low as $399.29, and closed at $400.76. Trading volume was a total of 805.90K shares.
VRTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vertex Pharmaceuticals shares, starting with a $10,000 purchase of VRTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$64.51 |
|
End price/share: |
$400.76 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
521.24% |
|
Average Annual Total Return: |
20.05% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$62,144.72 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $393.48 | 04/19/2024 | $394.28 | 04/22/2024 | $399.92 | 04/23/2024 | $404.91 | 04/24/2024 | $400.76 |
|
|